242 related articles for article (PubMed ID: 26332237)
21. Eosinophilic chronic rhinosinusitis in Japan.
Ishitoya J; Sakuma Y; Tsukuda M
Allergol Int; 2010 Sep; 59(3):239-245. PubMed ID: 20657162
[TBL] [Abstract][Full Text] [Related]
22. Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps.
Kato A; Peters A; Suh L; Carter R; Harris KE; Chandra R; Conley D; Grammer LC; Kern R; Schleimer RP
J Allergy Clin Immunol; 2008 Jun; 121(6):1385-92, 1392.e1-2. PubMed ID: 18410958
[TBL] [Abstract][Full Text] [Related]
23. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
Lieber G; Jimenez J; Hunter JC; McLeod RL; Jia Y
Pharmacology; 2010; 85(5):311-8. PubMed ID: 20453555
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor-α receptor expression correlates with mucosal changes and biofilm presence in chronic rhinosinusitis with nasal polyposis.
Karosi T; Csomor P; Sziklai I
Laryngoscope; 2012 Mar; 122(3):504-10. PubMed ID: 22231697
[TBL] [Abstract][Full Text] [Related]
25. Pathological mechanisms and clinical features of eosinophilic chronic rhinosinusitis in the Japanese population.
Takeno S; Hirakawa K; Ishino T
Allergol Int; 2010 Sep; 59(3):247-256. PubMed ID: 20567131
[TBL] [Abstract][Full Text] [Related]
26. Effects of leukotriene receptor antagonist therapy in patients with chronic rhinosinusitis in a real life rhinology clinic setting.
Wilson AM; White PS; Gardiner Q; Nassif R; Lipworth BJ
Rhinology; 2001 Sep; 39(3):142-6. PubMed ID: 11721504
[TBL] [Abstract][Full Text] [Related]
27. Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma.
Steinke JW; Bradley D; Arango P; Crouse CD; Frierson H; Kountakis SE; Kraft M; Borish L
J Allergy Clin Immunol; 2003 Feb; 111(2):342-9. PubMed ID: 12589355
[TBL] [Abstract][Full Text] [Related]
28. [Zafirlukast in treatment of nasal polyps in patients with aspirin intolerant bronchial asthma--preliminary report].
Modrzyński M; Zawisza E; Rapiejko P
Pol Merkur Lekarski; 2002 Mar; 12(69):224-7. PubMed ID: 12053594
[TBL] [Abstract][Full Text] [Related]
29. Chronic rhinosinusitis--need for further classification?
Rudack C; Sachse F; Alberty J
Inflamm Res; 2004 Mar; 53(3):111-7. PubMed ID: 15021966
[TBL] [Abstract][Full Text] [Related]
30. Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Chronic Rhinosinusitis With Nasal Polyps: Etiopathogenesis and Recurrence.
Guerra G; Testa D; Salzano FA; Tafuri D; Hay E; Schettino Bs A; Iovine R; Marcuccio G; Motta G
Ear Nose Throat J; 2021 Sep; 100(5_suppl):597S-605S. PubMed ID: 31893934
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expressions of TAM receptors are associated with postoperative recurrence in chronic rhinosinusitis with nasal polyps.
Zhou Y; Feng Z; Wen J; Yang C; Jing Q
Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3005-3015. PubMed ID: 38233691
[TBL] [Abstract][Full Text] [Related]
32. Expression and role of acidic mammalian chitinase and eotaxin-3 in chronic rhinosinusitis with nasal polyps.
Gu Z; Cao Z; Jin M
J Otolaryngol Head Neck Surg; 2011 Feb; 40(1):64-9. PubMed ID: 21303604
[TBL] [Abstract][Full Text] [Related]
33. Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptor.
Ramanathan M; Spannhake EW; Lane AP
Laryngoscope; 2007 Oct; 117(10):1839-43. PubMed ID: 17906500
[TBL] [Abstract][Full Text] [Related]
34. The expression of TSLP receptor in chronic rhinosinusitis with and without nasal polyps.
Boita M; Garzaro M; Raimondo L; Riva G; Mazibrada J; Vizio B; Bellone G; Pecorari G; Bucca C; Rolla G; Giordano C
Int J Immunopathol Pharmacol; 2011; 24(3):761-8. PubMed ID: 21978707
[TBL] [Abstract][Full Text] [Related]
35. Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps.
Takabayashi T; Kato A; Peters AT; Suh LA; Carter R; Norton J; Grammer LC; Tan BK; Chandra RK; Conley DB; Kern RC; Fujieda S; Schleimer RP
J Allergy Clin Immunol; 2012 Aug; 130(2):410-20.e5. PubMed ID: 22534535
[TBL] [Abstract][Full Text] [Related]
36. Butyrate inhibits type 2 inflammation in eosinophilic chronic rhinosinusitis.
Toyama M; Kouzaki H; Shimizu T; Hirakawa H; Suzuki M
Biochem Biophys Res Commun; 2024 Jun; 714():149967. PubMed ID: 38669752
[TBL] [Abstract][Full Text] [Related]
37. Predictive Value of Eosinophil Cationic Protein in Nasal Secretions in Eosinophilic Chronic Rhinosinusitis.
Jin J; Guo B; Zhang W; Chen JJ; Deng YQ; Xiang R; Tan L; Liu PQ; Zheng L; Chen Z; Tao ZZ; Xu Y
Laryngoscope; 2023 Dec; 133(12):3304-3312. PubMed ID: 37255052
[TBL] [Abstract][Full Text] [Related]
38. The role of leukotrienes in nasal allergy.
Haberal I; Corey JP
Otolaryngol Head Neck Surg; 2003 Sep; 129(3):274-9. PubMed ID: 12958580
[TBL] [Abstract][Full Text] [Related]
39. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma.
Ragab S; Parikh A; Darby YC; Scadding GK
Clin Exp Allergy; 2001 Sep; 31(9):1385-91. PubMed ID: 11591188
[TBL] [Abstract][Full Text] [Related]
40. Residual nasal polyp tissue following dupilumab therapy is associated with periostin-associated fibrosis.
Suzaki I; Maruyama Y; Kamimura S; Hirano K; Nunomura S; Izuhara K; Kobayashi H
Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):1807-1817. PubMed ID: 37979011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
